Lipschütz acute vulvar ulcer related to COVID-19 vaccination: First case report in South America
- Lucero Sangster-Carrasco,
- Romario Paz-Temoche,
- Julia Coronado-Arroyo,
- ,
- Pela Roseboom,
- Luis Concepción-Urteaga
- Universidad Peruana de Ciencias Aplicadas,
- Universidad Nacional de Trujillo,
- Hospital Nacional Edgardo Rebagliati Martins, EsSalud,
- ,
- Cesar Vallejo Mendoza Hospital,
- Servicio de Neurología. Hospital Regional Docente de Trujillo-MINSA
Open access
Publication Information
Output type
Original language
EnglishArticle number
e2674Journal (Volume, Issue Number)
Medwave (Volume 23, Issue 2)Publication milestones
- Published - 03/2023
Publication status
Publication IDs
- Scopus: 85150834934
- PubMed: 36947719
Abstract
Lipschütz ulcer is a non-sexually transmitted genital lesion of unknown etiology, which pres-ents as a painful vulvar ulcer. Lipschütz ulcers have been described in most continents. This is the first case reported in Peru and South America. We present the case of a 33-year-old female patient with a Lipschütz ulcer after being vaccinated with the second dose of the AstraZeneca COVID-19 vaccine. She reported having had only one sexual partner in her lifetime. Laboratory results were negative for herpes simplex 2, Cytomegalovirus, Toxoplasma gondii, Epstein-Barr virus, and syphilis. The patient received symptomatic treatment. Ten days after the onset, the patient was significantly better during follow-up. This case report displays a potential adverse effect of the AstraZeneca COVID-19 vaccine as a Lipschütz ulcer triggered by the host humoral immune response. However, further research is needed to establish the causal relationship between these two.
Publication metrics
Metrics
Sustainable Development Goals
- SDG 3 Good Health and Well
